BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 16925995)

  • 1. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
    Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
    Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus.
    Kassuya CA; Leite DF; de Melo LV; Rehder VL; Calixto JB
    Planta Med; 2005 Aug; 71(8):721-6. PubMed ID: 16142635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytotoxic effect and the multidrug resistance reversing action of lignans from Phyllanthus amarus.
    Leite DF; Kassuya CA; Mazzuco TL; Silvestre A; de Melo LV; Rehder VL; Rumjanek VM; Calixto JB
    Planta Med; 2006 Dec; 72(15):1353-8. PubMed ID: 17054045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yangambin, a lignan obtained from Ocotea duckei, differentiates putative PAF receptor subtypes in the gastrointestinal tract of rats.
    Jesus-Morais CM; Assis EF; Cordeiro RS; Barbosa-Filho JM; Lima WT; Silva ZL; Bozza PT; Castro-Faria-Neto HC
    Planta Med; 2000 Apr; 66(3):211-6. PubMed ID: 10821044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
    Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
    Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain.
    Kassuya CA; Silvestre AA; Rehder VL; Calixto JB
    Eur J Pharmacol; 2003 Oct; 478(2-3):145-53. PubMed ID: 14575799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiinflammatory effects of Tacrolimus in a mouse model of pleurisy.
    Pereira R; Medeiros YS; Fröde TS
    Transpl Immunol; 2006 Aug; 16(2):105-11. PubMed ID: 16860713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lignans with anti-hepatitis B virus activities from Phyllanthus niruri L.
    Wei W; Li X; Wang K; Zheng Z; Zhou M
    Phytother Res; 2012 Jul; 26(7):964-8. PubMed ID: 22131154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-edematogenic effects of velutinol A isolated from Mandevilla velutina: evidence for a selective inhibition of kinin B1 receptor-mediated responses.
    Mattos WM; Campos MM; Fernandes ES; Richetti GP; Niero R; Yunes RA; Calixto JB
    Regul Pept; 2006 Sep; 136(1-3):98-104. PubMed ID: 16764951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor.
    Gurun MS; Parker R; Eisenach JC; Vincler M
    Anesth Analg; 2009 May; 108(5):1680-7. PubMed ID: 19372354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllanthus amarus does not affect hypernociception in experimental autoimmune encephalomyelitis.
    Molska GR; Negri G; Paula-Freire LI; Araujo LP; Köhn DO; Basso AS; Carlini EA
    Planta Med; 2014 Mar; 80(4):277-82. PubMed ID: 24610345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L.
    Liu S; Wei W; Shi K; Cao X; Zhou M; Liu Z
    J Ethnopharmacol; 2014 Sep; 155(2):1061-7. PubMed ID: 25009077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
    Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.